Mupirocin
Clinical data | |
---|---|
Trade names | Bactroban, others |
Other names | muciprocin[1] |
AHFS/Drugs.com | Monograph |
MedlinePlus | a688004 |
License data | |
Pregnancy category |
|
Topical | |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Protein binding | 97% |
Elimination half-life | 20 to 40 minutes |
Identifiers | |
| |
JSmol) | |
Melting point | 77 to 78 °C (171 to 172 °F) |
| |
| |
(what is this?) (verify) |
Mupirocin, sold under the brand name Bactroban among others, is a topical
Common side effects include itchiness and rash at the site of application, headache, and nausea.
Mupirocin was initially isolated in 1971 from
Medical uses
Mupirocin is used as a topical treatment for bacterial skin infections (for example, boils, impetigo, or open wounds), which are typically due to infection by Staphylococcus aureus or Streptococcus pyogenes. It is also useful in the treatment of superficial methicillin-resistant Staphylococcus aureus (MRSA) infections.[14] Mupirocin is inactive for most anaerobic bacteria, mycobacteria, mycoplasma, chlamydia, yeast, and fungi.[15]
Intranasal mupirocin before surgery is effective for prevention of post-operative wound infection with Staphylcoccus aureus and preventative intranasal or catheter-site treatment is effective for reducing the risk of catheter site infection in persons treated with chronic peritoneal dialysis.[16]
Resistance
Shortly after the clinical use of mupirocin began, strains of Staphylococcus aureus that were
Most strains of
Most strains of Pseudomonas fluorescens are also resistant to mupirocin as they produce the antibiotic and it's possible other species of Pseudomonas may be resistant as well. [citation needed]
The mechanism of action of mupirocin differs from other clinical antibiotics, rendering cross-resistance to other antibiotics unlikely.[17] However, the MupA gene may co-transfer with other antibacterial resistance genes. This has been observed already with resistance genes for triclosan, tetracycline, and trimethoprim.[17] It may also result in overgrowth of non-susceptible organisms.[citation needed]
A second type of high-level resistant synthetase was discovered in 2012 and termed MupB. It was found in a Canadian MRSA isolate "MUP87" and is probably located on a nonconjugative plasmid.[22]
Mechanism of action
Pseudomonic acid inhibits
Inhibition of the tRNA ligase/synthase is brought by the structural similarity between the molecule's monic acid "head" part and isoleucyl-
Biosynthesis
Mupirocin is a mixture of several pseudomonic acids, with pseudomonic acid A (PA-A) constituting greater than 90% of the mixture. Also present in mupirocin are pseudomonic acid B with an additional hydroxyl group at C8,[29] pseudomonic acid C with a double bond between C10 and C11, instead of the epoxide of PA-A,[30] and pseudomonic acid D with a double bond at C4` and C5` in the 9-hydroxy-nonanoic acid portion of mupirocin.[31]
Biosynthesis of pseudomonic acid A
The 74
Pseudomonic acid A is the product of an
Gene | Function |
---|---|
mupA | FMNH2 dependent oxygenase |
mmpA | ACP KS ACP ACP |
mupB | 3-oxoacyl-ACP synthase |
mmpB | KS DH KR ACP ACP ACP TE |
mmpC | AT AT |
mmpD | KS DH KR MeT ACP KS DH KR ACP KS DH KR MeT ACP KS KR ACP |
mupC | NADH/NADPH oxidoreductase |
macpA | ACP |
mupD | 3-oxoacyl-ACP reductase |
mupE | enoyl reductase |
macpB | ACP |
mupF | KR |
macpC | ACP |
mupG | 3-oxoacyl-ACP synthase I |
mupH | HMG-CoA synthase |
mupJ | enoyl-CoA hydratase |
mupK | enoyl-CoA hydratase |
mmpE | KS hydrolase |
mupL | putative hydrolase |
mupM | isoleucyl-tRNA synthase
|
mupN | phosphopantetheinyl transferase
|
mupO | cytochrome P450 |
mupP | unknown |
mupQ | acyl-CoA synthase |
mupS | 3-oxoacyl-ACP reductase
|
macpD | ACP |
mmpF | KS |
macpE | ACP |
mupT | ferredoxin dioxygenase |
mupU | acyl-CoA synthase |
mupV | oxidoreductase |
mupW | dioxygenase |
mupR | transcriptional activator
|
mupX | amidase/hydrolase |
mupI | N-AHL synthase |
Monic acid biosynthesis
Biosynthesis of the 17C monic acid unit begins on MmpD (Figure 1).[27] One of the AT domains from MmpC may transfer an activated acetyl group from acetyl-Coenzyme A (CoA) to the first ACP domain. The chain is extended by malonyl-CoA, followed by a SAM-dependent methylation at C12 (see Figure 2 for PA-A numbering) and reduction of the B-keto group to an alcohol. The dehydration (DH) domain in module 1 is predicted to be non-functional due to a mutation in the conserved active site region. Module 2 adds another two carbons by the malonyl-CoA extender unit, followed by ketoreduction (KR) and dehydration. Module three adds a malonyl-CoA extender unit, followed by SAM-dependent methylation at C8, ketoreduction, and dehydration. Module 4 extends the molecule with a malonyl-CoA unit followed by ketoreduction.[citation needed]
Assembly of monic acid is continued by the transfer of the 12C product of MmpD to MmpA.[27]
Post-PKS tailoring
The keto group at C3 is replaced with a methyl group in a multi-step reaction (Figure 3). MupG begins by
The formation of the pyran ring requires many enzyme-mediated steps (Figure 4). The double bond between C8 and C9 is proposed to migrate to between C8 and C16.[28] Gene knockout experiments of mupO, mupU, mupV, and macpE have eliminated PA-A production.[28] PA-B production is not removed by these knockouts, demonstrating that PA-B is not created by hydroxylating PA-A. A knockout of mupW eliminated the pyran ring, identifying MupW as being involved in ring formation.[28]
The epoxide of PA-A at C10-11 is believed to be inserted after pyran formation by a cytochrome P450 such as MupO.[27] A gene knockout of mupO abolished PA-A production but PA-B, which also contains the C10-C11 epoxide, remained.[28]
9-Hydroxy-nonanoic acid biosynthesis
The nine-carbon
It is proposed that MmpB to catalyzes the synthesis of 9-HN (Figure 5). MmpB contains a KS, KR, DH, 3 ACPs, and a thioesterase (TE) domain.[27] It does not contain an enoyl reductase (ER) domain, which would be required for the complete reduction to the nine-carbon fatty acid. MupE is a single-domain protein that shows sequence similarity to known ER domains and may complete the reaction.[27]
References
- ISBN 9780071379953. Archivedfrom the original on 10 September 2017.
- ^ "Prescription medicines: registration of new generic medicines and biosimilar medicines, 2017". Therapeutic Goods Administration (TGA). 21 June 2022. Retrieved 30 March 2024.
- ^ "Bactroban Product information". Health Canada. 22 October 2009. Archived from the original on 26 February 2023. Retrieved 26 February 2023.
- ^ "Bactroban (mupirocin) cream, for topical use Initial U.S. Approval: 1997". DailyMed. Archived from the original on 26 February 2023. Retrieved 26 February 2023.
- PMID 27184545.
- ^ a b c d e f g "Mupirocin". The American Society of Health-System Pharmacists. Archived from the original on 21 December 2016. Retrieved 8 December 2016.
- ^ ISBN 9789241547659.
- ISBN 9780387789408. Archivedfrom the original on 10 September 2017.
- ISBN 9780849351297. Archivedfrom the original on 10 September 2017.
- hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- ^ "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
- ^ "Mupirocin - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.
- ^ "Competitive Generic Therapy Approvals". U.S. Food and Drug Administration (FDA). 29 June 2023. Archived from the original on 29 June 2023. Retrieved 29 June 2023.
- ^ PMID 365175.
- ^ "Product Monograph Bactroban" (PDF). Archived (PDF) from the original on 24 September 2015. Retrieved 8 September 2014.
- PMID 30376041.
- ^ PMID 9511032.
- ^ Worcester S (March 2008). "Topical MRSA Decolonization Is Warranted During Outbreaks". American College of Emergency Physicians. Elsevier Global Medical News. Archived from the original on 18 May 2014. Retrieved 18 November 2013.
- PMID 7929087.
- PMID 8431015.
- ^ "Antibiotic Susceptibility of Propionibacterium acnes". ScienceOfAcne.com. 11 June 2011. Archived from the original on 29 July 2012. Retrieved 27 August 2012.
- S2CID 21526116.
- PMID 4576025.
- PMID 4982424.
- PMID 11584022.
- S2CID 211263261.
- ^ PMID 12770824.
- ^ PMID 16039529.
- PMID 402373.
- .
- .
- ^ PMID 402372.
- .